Haw Par Corporation Limited (H02.SI)

Haw Par Corporation Limited (H02.SI) — VMCI valuation read

H02.SI screens at VMCI 62/100, a 12-point gap above the Healthcare sector median (50). For a mid-cap Haw Par Corporation Limited share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

H02.SI has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: H02.SI trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 12.0% sits 2.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of 2.0x is the rate-sensitivity line to watch, which sets the rate-cycle exposure for Haw Par Corporation Limited.

H02.SI rose 2.8% over the trailing 7 days, with a -14.6% read on a 30-day basis.